Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Biogen Inc
Sanofi SA
US: News
From
CNBC.com News
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
July 21, 2025
Tags
Sarepta Therapeutics Inc
Amgen Inc
Business News
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Markets
Merck & Co Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
Tags
Business
Breaking News: Earnings
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
February 10, 2025
Tags
Markets
Restaurant Brands International Inc
Politics
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
LILLY DRN
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Business News
Pharmaceuticals
Companies
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
GSK plc
Stock markets
LILLY DRN
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Exxon Mobil Corp
CrowdStrike Holdings Inc
Business News
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
Live Nation Entertainment Inc
WW Grainger Inc
Parker/Hannifin Corp
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
Biogen Inc
Boeing Co
Investing
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Biotech and Pharmaceuticals
Breaking News: Business
Breaking news
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Earnings
Breaking news
Biotech and Pharmaceuticals
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Business
Breaking News: Business
Biotech and Pharmaceuticals
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Science
Business News
Eli Lilly and Co
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Eisai Co Ltd
US: News
Biotechnology
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Eisai Co Ltd
Investing
U/S/ Markets
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Stock Picks
Chevron Corp
S&P 500
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
US: News
Eisai Co Ltd
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Merck & Co Inc
Humana Inc
Enphase Energy Inc
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Business
Biotech and Pharmaceuticals
Companies
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Health & Science
Health care industry
Biogen Inc
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Companies
Health care industry
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Investing
DraftKings Inc
Microsoft Corp
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Biotech and Pharmaceuticals
Business
Health & Science
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Amgen Inc
Eli Lilly and Co
Business News
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Lucid Group Inc
Technology
Business
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Biotech and Pharmaceuticals
Breaking news
Business
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Health & Science
Biogen Inc
Biotechnology
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Exxon Mobil Corp
First Solar Inc
Mondelez International Inc
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.